By Working Party—Rasmussen, Foskett, Mason, Pace, Passmore and Serpell2014-06-01T00:00:00
This guideline was developed by a multidisciplinary expert panel: Rasmussen J et al with the support of a grant from Napp Pharmaceuticals Ltd.
Register for free
Already have an account?Sign in
Or pay £5 to continue reading and receive unlimited access for 30 days
Site powered by Webvision Cloud